CA Patent

CA3093725C — Epinephrine compositions and containers

Assigned to Nevakar Injectables Inc · Expires 2021-08-24 · 5y expired

What this patent protects

The inventive subject matter provides ready-to-administer, preferably anti-oxidant free, epinephrine compositions with improved stability, and methods for preparing the same. Contemplated compositions can be packaged using blow-fill-seal technology or packaged into flexible IV ba…

USPTO Abstract

The inventive subject matter provides ready-to-administer, preferably anti-oxidant free, epinephrine compositions with improved stability, and methods for preparing the same. Contemplated compositions can be packaged using blow-fill-seal technology or packaged into flexible IV bags and maintain degradation of the epinephrine at a level of less than 5 wt% when stored over at least one months at between 2-40 °C.

Drugs covered by this patent

Patent Metadata

Patent number
CA3093725C
Jurisdiction
CA
Classification
—
Expires
2021-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Nevakar Injectables Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.